BE888906A - Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal - Google Patents
Procede de preparation d'un antigene et d'un anticorps du glucagon intestinalInfo
- Publication number
- BE888906A BE888906A BE0/204863A BE204863A BE888906A BE 888906 A BE888906 A BE 888906A BE 0/204863 A BE0/204863 A BE 0/204863A BE 204863 A BE204863 A BE 204863A BE 888906 A BE888906 A BE 888906A
- Authority
- BE
- Belgium
- Prior art keywords
- antibody
- preparation
- antigen
- intestinal glucagon
- intestinal
- Prior art date
Links
- 102000051325 Glucagon Human genes 0.000 title 1
- 108060003199 Glucagon Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title 1
- 229960004666 glucagon Drugs 0.000 title 1
- 230000000968 intestinal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/822—Identified hapten
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/823—Immunogenic carrier or carrier per se
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6804080A JPS56163456A (en) | 1980-05-21 | 1980-05-21 | Preparation of antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE888906A true BE888906A (fr) | 1981-11-23 |
Family
ID=13362282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/204863A BE888906A (fr) | 1980-05-21 | 1981-05-21 | Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4407965A (en, 2012) |
| JP (1) | JPS56163456A (en, 2012) |
| BE (1) | BE888906A (en, 2012) |
| DE (1) | DE3120312C2 (en, 2012) |
| DK (1) | DK159163C (en, 2012) |
| FR (1) | FR2482861A1 (en, 2012) |
| GB (1) | GB2079289B (en, 2012) |
| SE (1) | SE454301B (en, 2012) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1249395A (en) * | 1982-09-30 | 1989-01-24 | Tetsuya Tachikawa | Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies |
| CA1256795A (en) * | 1983-12-28 | 1989-07-04 | Dennis A. Carson | Anti-idiotype antibodies induced by synthetic polypeptides |
| US4545985A (en) * | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
| GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
| US5116725A (en) * | 1984-08-08 | 1992-05-26 | Scripps Clinic And Research Foundation | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
| US4654419A (en) * | 1984-08-08 | 1987-03-31 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| WO1986001834A1 (en) * | 1984-09-19 | 1986-03-27 | The Regents Of The University Of California | Retroviral polypeptides associated with human cellular transformation |
| US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
| JPH0792458B2 (ja) * | 1986-03-14 | 1995-10-09 | 郁男 山科 | 糖鎖特異抗体アツセイプレ−ト及びその製造方法 |
| US5202270A (en) * | 1986-05-15 | 1993-04-13 | Abbott Laboratories | Cocaine and cocaine metabolites assay tracers, immunogens and antibodies |
| US6919076B1 (en) | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| US6958148B1 (en) | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
| SG11201701711VA (en) | 2014-09-16 | 2017-04-27 | Regeneron Pharma | Anti-glucagon antibodies and uses thereof |
| MX385598B (es) | 2016-08-30 | 2025-03-18 | Regeneron Pharma | Anticuerpo inhibidor para usarse para tratar la resistencia severa a la insulina. |
| WO2018075792A1 (en) | 2016-10-20 | 2018-04-26 | Regeneron Pharmaceuticals, Inc. | Methods of lowering blood glucose levels |
| JP2020531532A (ja) | 2017-08-22 | 2020-11-05 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | グルカゴン受容体シグナル伝達に干渉することによって尿素サイクル異常症を治療する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5836308B2 (ja) * | 1977-02-10 | 1983-08-08 | 大塚製薬株式会社 | 抗体の製造方法 |
| US4206199A (en) * | 1977-07-22 | 1980-06-03 | Takeda Chemical Industries, Ltd. | Novel glucagon fragment and its derivatives |
-
1980
- 1980-05-21 JP JP6804080A patent/JPS56163456A/ja active Granted
-
1981
- 1981-05-20 DK DK222081A patent/DK159163C/da not_active IP Right Cessation
- 1981-05-20 SE SE8103198A patent/SE454301B/sv not_active IP Right Cessation
- 1981-05-21 US US06/265,926 patent/US4407965A/en not_active Expired - Lifetime
- 1981-05-21 FR FR8110140A patent/FR2482861A1/fr active Granted
- 1981-05-21 DE DE3120312A patent/DE3120312C2/de not_active Expired
- 1981-05-21 GB GB8115648A patent/GB2079289B/en not_active Expired
- 1981-05-21 BE BE0/204863A patent/BE888906A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE454301B (sv) | 1988-04-18 |
| DK222081A (da) | 1981-11-22 |
| DK159163B (da) | 1990-09-10 |
| DE3120312C2 (de) | 1985-08-29 |
| GB2079289B (en) | 1983-10-26 |
| GB2079289A (en) | 1982-01-20 |
| DE3120312A1 (de) | 1982-03-04 |
| DK159163C (da) | 1991-02-11 |
| FR2482861A1 (fr) | 1981-11-27 |
| JPS56163456A (en) | 1981-12-16 |
| JPS6223822B2 (en, 2012) | 1987-05-25 |
| FR2482861B1 (en, 2012) | 1983-09-09 |
| SE8103198L (sv) | 1981-11-22 |
| US4407965A (en) | 1983-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE863810A (fr) | Procede de preparation d'un antigene et d'un anticorps | |
| FR2500166B1 (fr) | Reactif et procede pour dosage immunologique d'antigenes | |
| IL55816A0 (en) | Method for simultanesous immunoassay of several different antibodies | |
| GB2111676B (en) | Device and method for determining the presence of antigens or antibodies | |
| BE888906A (fr) | Procede de preparation d'un antigene et d'un anticorps du glucagon intestinal | |
| ES537929A0 (es) | Un metodo de obtencion de factor de transferencia excretado (fte) especifico de un antigeno | |
| NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
| FR2322373A1 (fr) | Methode et necessaire de dosage immunologique d'un antigene en phase solide | |
| EP0034050A3 (en) | Immunoassay of antigens | |
| BE896853A (fr) | Procede et dispositif de preparation d'objets creux en matiere ceramique. | |
| FR2522679B1 (fr) | Procede pour la production d'anticorps monoclonaux humains | |
| BE866226A (fr) | Procede pour la preparation de thymosine alpha1 et d'un analogue | |
| SG57984G (en) | Immunoassay for class specific antibodies | |
| BE866096A (fr) | Antigene du noyau d'hepatite b et procede pour sa preparation | |
| BE874166R (fr) | Procede et dispositif pour realiser la mesure et le dosage d'antigenes et d'anticorps | |
| DK98187D0 (da) | Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma | |
| GB2015156B (en) | Determination of antigens of antibodies | |
| IT8249646A0 (it) | Particelle per viraggio elettrofotografico e procedimento per ottenere detto prodotto | |
| DE3373214D1 (en) | Method of measuring infectious disease antibodies | |
| BE857327A (fr) | Procede d'isolement et de recuperation d'hormones proteiques | |
| NZ195756A (en) | Human cancer cell-associated nucleolar antigens and antibodies thereto;immunological detection of cancer | |
| BE889604A (fr) | Procede de preparation d'acetaldehyde et d'ethanol | |
| DE2966772D1 (en) | Electrostatographic developer mixture and imaging process | |
| BE846822A (fr) | Procede pour deceler l'antigene et les anticorps de l'hepatite et vaccin contre l'hepatite | |
| FR2511155B1 (fr) | Detection d'anticorps auto-bloquant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: OTSUKA PHARMACEUTICAL CO. LTD Effective date: 19980531 |